Carregant...
Target HER four in breast cancer?
The HER4 receptor tyrosine kinase is known to have promiscuous activity in malignant cells, last but not least in breast cancer. Evidently, the prognostic and predictive impact of HER4 expression depends on the expression of different receptor isotypes, the way of receptor activation (ligand depende...
Guardat en:
| Publicat a: | Oncotarget |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Impact Journals LLC
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6516717/ https://ncbi.nlm.nih.gov/pubmed/31139328 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.26867 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|